期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HIV/AIDS初始抗反转录病毒治疗新进展 被引量：2

Advances in initial antiretroviral therapy for HIV/AIDS
原文传递
导出
摘要 1996年以来,HIV/AIDS的治疗已经发生了惊人的变化。近年来,一些ART新药上市,且在治疗时机及治疗方案的选择等方面的研究都取得了一些新进展。本文结合国内外最新的指南,就这些方面的研究新进展进行了综述。 The management of HIV/AIDS has undergone significant change since 1996. Several new ART drugs have recently been marketed, and there have also been advances in the timing of antiretroviral therapy and treatment regimens. These topics are reviewed here.
作者 代丽丽 张彤 李在村
机构地区 首都医科大学附属北京佑安医院感染科
出处 《中国病原生物学杂志》 CSCD 北大核心 2012年第6期469-472,共4页 Journal of Pathogen Biology
基金 国家自然科学基金项目(No.30872226)
关键词 AIDS 抗反转录病毒治疗 综述 AIDS ART review
分类号 R512.91 [医药卫生—内科学]
  • 相关文献

参考文献15

  • 1AIDSINFO. http://www, aidsinfoonline, org/Drugs/lnforma- tionon HIV/AIDS related drugs/FDA-Approved HIV/AIDS Drugs.
  • 2Chun TW, Engel D, Berrey MM, et al. Early establishment of a pool of latently infected, resting CD4 (+) T ceils during primary HIV-1 infection. Proc Natl Acad Sei USA, 1998, 95(15): 8869 - 73.
  • 3Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-l-infected adults and adolescents. Department of health and human serv- ices(DHHS), October 14, 2011.
  • 4中国疾病预防控制中心.国家免费艾滋病抗病毒药物治疗手册[M].北京:人民卫生出版社,2004:89-95.
  • 5Wood E, Montaner JS. Time to get serious about HIV antiretro- viral resistance. Lancet Infect Dis, 2011, 11(10): 723--4.
  • 6Worm SW, Sabin C, Weber R, et al, Risk of myocardial infarc-tion in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data col- lection on adverse events of anti-HIV drugs (D: A: D) study. J Infect Dis, 2010, 201(3): 318--30.
  • 7Roekstroh JK, Lennox JL, Dejesus E, et al. Long-term treat- ment with rahegravir or efavirenz combined with tenofovir/ emtricitabine for treatment-naive human immunodeficiency vi- rus-1-infected patients: 156-week results from STARTMRK [J]. Ciin Inject Dis, 2011, 5a(8) : 807--16.
  • 8Cooper DA, Heera J, Goodrich J, et al. Maraviroc versus efa- virenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCRS-tropic HIV-linfection[J]. J Infect Dis, 2010, 201(6): 803--13.
  • 9Cohen C J, Andrade-Villanueva J, Clotet B, et al. Rilpivirine ver- sus efavirenz with two background nueleoside or nucleotide re- verse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE) : a phase 3, randomised, non-inferiority trial[J]. Lancet, 2011, 378(9787): 229--37.
  • 10Molina JM, Cahn P, Grinsztejn B, et al. Rilpivirine versus efa- virenz with tenofovir and emtricitabine in treatment naive adults infected with HIV-1 (ECHO): a phase 3 randomised double- blind active-controlled trial[J]. Lancet, 2011, 378(9787): 238 --46.

共引文献3

同被引文献37

  • 1Marcela fogaca Vieira,renata reis,Gabriela costa chaves,胡安琪.巴西的药品可及性与知识产权问题:民间社会的反应和策略[C].专利法研究(2008),北京,2009:162-185.
  • 2AIDS Clinical Trials Group. Division of AIDS table for grading the severity of adult and pediatric adverse events. Clarification,2009.
  • 3Marina NtSflez. Hepatotoxicity of antiretrovirals: Incidence, mech- anisms and management[J]. J Hepatology, 2006,44 ( 1 ) : 132-139.
  • 4Mamta K. Jain, MD, MPH. Drug-Induced Liver Injury Associated with HIV Medications. Clin Liver Dis,2007,11(6) ..615-639.
  • 5Esteban Martinez,Jose L. Blanco. Hepatotoxicity in HIV-l-infec- ted patients receiving nevirapine containing antiretroviral therapy [J]. AIDS,2001,15(12) : 1261-1268.
  • 6Kathryn M. Chu, Andrew M. Boulle Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Arica[J]. PLoS ONE,2010,5(2): 205 208.
  • 7史蒂文.罗宾斯,刘琪,黄剑波.从“权利”到“仪式”:南非的艾滋病行动主义[J].广西民族研究,2007(4):45-57. 被引量：2
  • 8中华人民共和国中央人民政府.中国艾滋病防控工作取得积极进展一访中国疾控中心性病艾滋病预防控制中心主任吴尊友[EB/OL].(2012-10-18)[2015438-07].http://www.Mgov.cn/j=g/2012-07/25/content_2191623.htm.
  • 9World Bank. World Development Indicators [ EB/OL ]. (2013-04-17) [ 2015-08-07 ]. http ://data. worldbank, org/ data-catalog/world-development-indicators.
  • 10WHO. Global Health Observatory [EB/OL]. (2013-04- 17) [ 2015-08-07 ]. http ://www. who. int/ghodata.

引证文献2

二级引证文献5

中国病原生物学杂志
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部